NL-OMON22790CompletedNot Applicable
Effect of brimonidine, measured with the Nerve Fibre Analyser, in patients with acute ischaemic optic neuropathy.
Not provided0 sites20 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 20
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Arteric or non-arteric AION.
Exclusion Criteria
- •1. Onset of symptoms > 5 days ago at presentation;
- •2. Inability to undergo GDx or HFA measurement.
Investigators
Similar Trials
Completed
Not Applicable
Effect of brimonidine, measured with the Nerve Fibre Analyser, in patients with acute ischaemic optic neuropathyAcute ischaemic optic neuropathyEye DiseasesOther disorders of eye and adnexaISRCTN58221074Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (The Netherlands)20
Not yet recruiting
Phase 3
Assessing the effect of brimonidine gel on the redness remained after pimplesIRCT20140212016557N11Shiraz University of Medical Sciences30
Completed
Not Applicable
Effect of prophylactic Brimonidine instillation on bleeding during Strabismus surgery in adultsEye DiseasesStrabismusISRCTN31792393Yonsei University College of Medicine (South Korea)90
Recruiting
Phase 3
Evaluation of neuroprotective effect of Brimonidine on visual indices in optic neuritis patientsOptic neuritisOptic neuritis.IRCT20221127056631N1Zahedan University of Medical Sciences60
Completed
Phase 4
Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin AnalogueOpen Angle GlaucomaOcular HypertensionNCT01937312Alcon Research282